Comparing the current results to its competitors, Mangoceuticals Inc reported Revenue decrease in the 2 quarter 2026 year on year by -59.1 %, despite the revenue increase by the most of its competitors of 45.59 %, recorded in the same quarter.
Mangoceuticals Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 24.95 %
Mangoceuticals Inc 's Comment on Competition and Industry Peers
Mangoceuticals, Inc. operates in the men's wellness product market. Its competitors in this sector include Hims & Hers Health, Inc. and Roman. For its erectile dysfunction (ED) products, Mangoceuticals faces competition from pharmaceutical companies offering branded drugs such as Viagra by Pfizer and Cialis marketed by Lilly ICOS LLC, a joint venture between Eli Lilly and Company and ICOS Corporation, as well as their generic equivalents. In the hair loss segment, Mangoceuticals competes with Merck & Co., which markets Propecia, and Johnson & Johnson, owner of Rogaine®, a branded form of Minoxidil. Additional competition arises from traditional healthcare providers, pharmacies, large retailers selling non-prescription products, and other companies with greater resources and advertising budgets offering similar compounded and pharmaceutical products. Mangoceuticals differentiates itself through branding, advertising, unique compounding, and product delivery systems.
Calumet Specialty Products Partners L.P. operates as a specialty petroleum products company, focusing on the production of high-quality lubricating oils and waxes. The company primarily refines crude oil to produce a range of petroleum-based products that are used in various industries including automotive, industrial, and consumer goods.
Hims and Hers Health Inc's business model is centered around providing direct-to-consumer telehealth services for a wide range of health and wellness needs.
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
Ringcentral Inc is a cloud-based communications and collaboration solutions provider that offers a unified communication platform to businesses, allowing them to streamline and modernize their communications processes. The company generates revenue by offering subscription-based services, including voice, video, messaging, and collaboration tools, to businesses of all sizes.
Sources:
Mangoceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mangoceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
